SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001013762-13-001011
Filing Date
2013-08-07
Accepted
2013-08-07 10:35:49
Documents
1
Period of Report
2013-08-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 5465
  Complete submission text file 0001013762-13-001011.txt   6898
Mailing Address SUITE 3 1545 WEST 14TH AVENUE VANCOUVER A1 V6J 2J1
Business Address
BACHA JEFFREY (Reporting) CIK: 0001432149 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54801 | Film No.: 131016220

Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Issuer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations